Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Academic Health Partners (OAHP) is delighted to have been designated as an NIHR/NHSE/I Academic Health Science Centre following the recent competitive designation process. The designation comes into effect from 1 April 2020 and is for an initial period of five years.

The OAHP includes Oxford Health NHS FT, Oxford University Hospitals NHS FT, Oxford Brookes University and the University of Oxford, who have been working closely together for the last six years in key areas including clinical research, multi-disciplinary education and healthcare innovations supporting the local needs and identified priorities.

OAHP’s vision is to respond to major challenges facing healthcare such as healthy ageing, multimorbidity and mental health, antimicrobial resistance and the best use of digital tools to improve care and patient self-management.

The OAHP is currently focusing their staff, facilities and expertise to overcome the COVID-19 pandemic, and using the close collaborations between the partners to make rapid progress in areas such as clinical trials of new treatments for COVID-19 patients in the NHS.  Daily examples of the excellent work and progress in this area can be seen across the media, with partners joining colleagues across the UK and beyond.

Professor Sir John Bell, Chairman of the OAHP said: “the strength of the partners and our plans are clear in all aspects of our work and our commitment to improve every aspect of patient care, research, innovation, education and training in ways that will benefit the changing NHS and its patients as a whole.”

Professor Keith Channon, Director of the OAHP, said: “This success reflects very strong working relationships between the Partners and the intention is now to deliver even more for current challenges, ongoing patient care, and in teaching, education and training and research and innovation.”

“Each partner has its own special set of skills and areas of expertise and together the OAHP can bring these together and work not only across Oxfordshire but regionally and nationally.”

Read more on the Oxford Academic Health Partners website

Similar stories

Communication at the crossroads of the immune system

In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.